<DOC>
	<DOCNO>NCT00373334</DOCNO>
	<brief_summary>The objective study evaluate efficacy , acceptability , safety Axid Oral Solution versus placebo treatment gastroesophageal reflux disease ( GERD ) infants age 30 day 1 year .</brief_summary>
	<brief_title>Safety Efficacy Study Axid Use Infants Suffering From Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Nizatidine</mesh_term>
	<criteria>Male female outpatient age 30 day 1 year Visit 1 . Subjects must document medical diagnosis gastroesophageal reflux disease ( GERD ) , confirm either endoscopy pH monitoring , evaluation baseline symptom . Subjects must great 3rd percentile weight height age . Parents/guardians competent willing provide consent sign date institutional review board ( IRB ) approve consent form . Parents/guardians willing adhere study requirement , include apply conservative GERD management method . Conservative GERD management method fail adequately control GERD symptom Visit 2 . Parent/guardian infant live household . Qualifying caregiver questionnaire score Visits 1 &amp; 2 . Any known esophageal disease disorder , reflux esophagitis . Any active gastroduodenal ulceration , clinical endoscopic evidence active gastrointestinal bleeding . Any prior esophageal gastric surgery . Concurrent serious systemic disorder , include chronic respiratory disease , chronic neurologic disease , chronic renal disease , chronic liver disease . Subjects clinically significant abnormal laboratory finding screen . Premature infant &lt; 37 week gestation birth . Infants prior neonatal intensive care unit admission reason . Hematemesis apparent lifethreatening event ( ALTE ) . Concurrent treatment chronic medication except permission study sponsor . Treatment histamine 2 receptor antagonist ( H2RA ) , antacid , sucralfate , prostaglandin , motility agent within 3 day Visit 1 ; treatment proton pump inhibitor within 7 day Visit 1 . Requirement likely requirement medical procedure surgery study . Known hypersensitivity H2RA include nizatidine . Receipt investigational agent within previous 30 day randomization . Poor medical psychiatric risk therapy investigational drug , opinion investigator . Any condition parent/guardian associate poor subject compliance e.g. , substance abuse ) ; inability parent/guardian return schedule visit child .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>heartburn</keyword>
</DOC>